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In Brief
Understanding the molecular basis of HIV Env-specific broadly neutralizing antibodies (bnAbs) development especially, at early stages, is key for germline-targeting vaccine design strategies. Umotoy et al. mapped the development of a VRC01-class bnAb lineage that achieved breadth in 2 years, revealing early binding to the N276-glycan during affinity maturation, which may have implications for vaccine design.
SUMMARY
The VH1-2 restricted VRC01-class of antibodies targeting the HIV envelope CD4 binding site are a major focus of HIV vaccine strategies. However, a detailed analysis of VRC01-class antibody development has been limited by the rare nature of these responses during natural infection and the lack of longitudinal sampling of such responses. To inform vaccine strategies, we mapped the development of a VRC01-class antibody lineage (PCIN63) in the subtype C infected IAVI Protocol C neutralizer PC063. PCIN63 monoclonal antibodies had the hallmark VRC01-class features and demonstrated neutralization breadth similar to the prototype VRC01 antibody, but were 2-to 3-fold less mutated. Maturation occurred rapidly within $24 months of emergence of the lineage and somatic hypermutations accumulated at key contact residues. This longitudinal study of broadly neutralizing VRC01-class antibody lineage reveals early binding to the N276-glycan during affinity maturation, which may have implications for vaccine design.
INTRODUCTION
Elicitation of broadly neutralizing antibodies (bnAbs) targeting the HIV envelope glycoprotein (Env) is thought to be a key component of a successful HIV-1 vaccine (Fauci, 2017) . VRC01-class antibodies, which target the conserved CD4 receptor binding site (CD4bs), are among the broadest neutralizing antibodies. However, these bnAbs typically display high levels of somatic hypermutation (SHM) (Falkowska et al., 2012; Huang et al., 2016; Scheid et al., 2011; Wu et al., 2010; Zhou et al., 2015) and often require years to develop during natural infection Lynch et al., 2012) . These features suggest that VRC01-class antibodies undergo a long and complex affinity maturation process and may be difficult to elicit by immunization.
VRC01-class antibodies have been isolated from several chronically HIV-infected individuals and differ by up to 42% in nucleotide sequence. However, antibodies of this class share common features (Wu et al., 2010; Zhou et al., 2015) Sajadi et al., 2018) including the use of a VH1-2 variable gene, a 5-residue LCDR3, and a short/flexible LCDR1. These shared features favor the rational design of immunogens to activate the precursors of VRC01-class bnAbs-so called germline-targeting immunogens McGuire et al., 2013) . Such immunogens have succeeded in eliciting narrowly neutralizing antibody responses with VRC01-class features in transgenic mouse models Dosenovic et al., 2015; Jardine et al., 2015; McGuire et al., 2016; Sok et al., 2016; Tian et al., 2016) . However, these responses lack the neutralization breadth associated with VRC01-class bnAbs isolated from chronic infection. Comparison between VRC01-class antibodies Jardine et al., 2013; McGuire et al., 2013) and subsequent design of minimally mutated VRC01-class antibodies highlighted the functional role of key ''patches'' of SHM that contribute to neutralization breadth and potency. The importance of these mutations was confirmed by comparing to the relatively strain-specific neutralizing DRVI07 antibody lineage, which harbored all the distinguishing features of VRC01-class antibodies except for the SHM in the light chain needed to accommodate the N276-and N462-glycans adjacent to the CD4bs (Kong et al., 2016) . These data indicate that accommodation of the glycans surrounding the CD4bs is a major hurdle for acquiring neutralization breadth that is typical for VRC01-class antibodies.
A detailed analysis of VRC01-class antibody development during infection has been limited by the rare nature of these responses during natural infection and the lack of longitudinal sampling of such responses. Furthermore, although germlinetargeting immunogens have successfully fished out naive precursors B cells with VRC01-like features from HIV-naive individuals (Jardine et al., 2016a; Havenar-Daughton et al., 2018) , whether these precursors are capable of leading to bnAbs is not known. Moreover, there is no clear pathway for the rapid elicitation of VRC01-class lineages and it is not known whether key mutations need to be introduced in a particular order.
In this study, we describe and map the rapid development of VRC01-class bnAbs in a subtype C-infected Protocol C participant, PC063, with clear CD4bs-targeting broadly neutralizing plasma activity . We report characterization of monoclonal antibodies isolated from this donor and outline the affinity maturation of the antibody lineage through next-generation sequencing and functional analyses. Overall, the elicitation and affinity maturation of VRC01-class antibodies in the PC063 donor challenges the notion that VRC01-class antibodies require high levels of somatic hypermutation and long periods of affinity maturation to gain neutralization breadth and potency. Additionally, we present data that suggests, in the case of the PCIN63 lineage, the presence of the N276 glycan adjacent to the CD4bs that commonly obstructs VRC01-class antibody binding might have offered favorable interactions to drive affinity maturation of this antibody lineage. The results of these findings have direct implications for HIV vaccine design strategies.
RESULTS

PCIN63
Antibodies Are Minimally Mutated VRC01-Class bnAbs Participant PC063 from the Protocol C cohort was shown previously to develop a CD4bs-directed bnAb response . Broadly neutralizing antibody activity was first detected in PC063 plasma at 54 months post infection (mpi), approximately 2 years later than observed for most Protocol C broad neutralizers and reached peak neutralization at 72 mpi ( Figure 1A ). To isolate the antibodies contributing to the plasma neutralization breadth in this donor, we used the previously described recombinant HIV Env (rgp140F) WT and D368R (CD4bs epitope knock-out) proteins (Li et al., 2012) . These proteins differentially adsorbed the broadly neutralizing activity from the plasma ( Figure S1A ) and were used as fluorophoreconjugated baits to sort CD4bs-specific memory B cells from peripheral blood mononuclear cells (PMBCs) samples collected at 66, 71, and 77 mpi ( Figure 1A ). Using this sort strategy, 18 mAbs, which define the PCIN63 lineage, were isolated ( Figure S1B ).
PCIN63 Abs derive from IGHV1-2*02/IGHJ5*02 and IGKV1-5*03/IGKJ1*01 genes, and exhibit characteristic features of VRC01-class bnAbs, including a 5-residue LCDR3 QxxEx motif, a flexible Gly-rich LCDR1 and a 15-residue HCDR3 containing a WxxxDx motif upstream of HFR4 ( Figure 1B , S1C, S1D, S2). Importantly, the SHM frequency of the PCIN63 lineage ranges from 9.6% to 16.0% (V H +J H ) and from 10.0% to 13.7% (V K +J K ) nucleotide mutation for the heavy (HC) and light (LC) chains, respectively, which is 2-to 3-fold lower than other VRC01-class bnAbs (Figures 1B and S1C) . Based on an alignment of PCIN63 mAbs amino acid sequences, the SHMs for this lineage accumulated at positions previously shown to be key epitope contact residues for the VRC01-class of bnAbs. These include mutations in HCDR1 and HCDR2, which are important for high-affinity binding to the gp120-Loop D and CD4bs-loop, and mutations in LCDR1 and LFR3 which reduce the steric clash with the N276-and N462-glycans on Env ( Figure S2 ) Jardine et al., 2016b) . Moreover, the neutralization breadth of PCIN63 bnAbs is equivalent to VRC01 on a large cross-clade panel of pseudoviruses (N = 134) despite lower mutation frequencies ( Figures 1B, 1C , Tables S1-S4 ). In fact, SHM in PCIN63 mAbs matched closely that of an engineered variant of mAb 12A21 designed to have the minimal set of SHM required for broadly neutralizing activity (min12A21) ( Figure S2 ) . The identification of PCIN63 Abs thus challenges previous notions that high levels of SHM and prolonged affinity maturation are required for neutralization breadth and potency.
The Rapid Development of the PCIN63 bnAb Lineage Is Not Due to High Naive B Cell Precursor Frequency Nor Biased AID Motifs The development of VRC01-class antibodies responses is rare compared to bnAbs targeting other epitopes (Li et al., 2007; Walker et al., 2010; Lynch et al., 2012 Rusert et al., 2016) . To determine whether the elicitation of VRC01-class antibodies in this donor was favored because of a higher frequency of VRC01-class precursors, we performed next-generation sequencing (NGS) of the naive peripheral B cell repertoire. The frequency of 5-residue LCDR3 B cells in the naive repertoire of PC063 was found to be slightly higher compared to HIV-naive donors from the United States (California) but similar to HIV-negative individuals from other African Protocol C sites ( Figure S3A) .
We next performed NGS on the peripheral IgG + B cell repertoire to determine whether the low frequency of SHM observed for PCIN63 might have been associated with the presence or absence of biased AID motifs in the antibody lineage sequences that would favor affinity maturation. A total of 17 time points between 4 and 77 mpi were processed to generate unpaired heavy-chain and light-chain sequences ( Figure S3 ). The PCIN63 lineage was first detected at 40 mpi with progressive accumulation of nucleotide mutations that plateaued at 67 mpi ( Figure S3C ). Although the emergence of the PCIN63 bnAb lineage in PC063 occurred almost 2-3 years later than other bnAb lineages from published co-evolution studies targeting the CD4bs (CH235, non-VRC01-class) (Bonsignori et al., 2016) , as well as other epitopes, the time required to reach maximum plasma breadth was overall similar (Figures 2A and S3B ). Delayed onset (between 37-42 mpi) and fast maturation (14-19 mpi) to breadth was also reported for the DH270, which is a V3-glycan targeting lineage (Bonsignori et al., 2017) . While comparison between independent studies is difficult to do accurately and plasma breadth does not necessarily correlate with frequency of SHM in the bnAb lineage, we verified that our estimation of time to maturation was overall consistent with the time to acquire some neutralization breadth in the earliest mAbs isolated from these lineages. We next evaluated whether the regions encoding for key contacts to HIV Env had an enrichment of AID hotspots that might have favored this rapid and highly focused affinity mutation to gain neutralization breadth, but no significant enrichments were found (Rogozin et al., 2001 , See methods). Overall, despite the relatively rapid development of VRC01-class antibodies in the PC063 donor, high precursor frequencies or biased AID motifs that might have accelerated affinity maturation and selection does not appear to be driving factors.
Longitudinal Sequence Analysis Identifies the Emergence of SHM Motifs Associated with Neutralization
Longitudinal evaluation of antibody lineages in natural infection can provide information on the order that SHM accumulates, (legend continued on next page) which can then inform rational vaccine strategies to elicit a similar sequence of events. Accordingly, for PC063, detailed analysis of SHM selection pathways could serve as template for elicitation of VRC01-class Abs. Thus, we tracked the emergence and evolution of seven PCIN63 SHM motifs over the course of infection ( Figure 2B ). These motifs were selected based on previous studies identifying the minimal SHM required for VRC01 and 12A21 broad neutralization . HCDR2-motif #2 (contacting CD4bs-loop) and LCDR2-motif#5 were first selected for, with mutations detected in nearly all sequences at month 40 at the emergence of the lineage (Figure 2C ). Selection of HCDR1-motif#1 (stabilizing HCDR2) and HFWR3-motif#3 (contacting V5 loop) residues quickly followed at month 42, then LCDR1-motif#4 (adaptation to N276-glycan) at 44 mpi and finally HFWR3-motif#6 (adaptation to N276-glycan) and LCDR3-motif#7 (contacting Loop D) at 49 mpi (Figure 2C) . Both HCDR2-motif #2 and HCDR1-motif#1 sampled a diversity of mutations between months 42 and 55 before converging on a final set of mutations at month 55 and month 66, respectively. In contrast, for LCDR2-motif#5 and HFWR3-motif#3, the sequences rapidly converged at month 44 to a predominant sequence, which then persisted through month 74. While LCDR3-motif#7 sampled several sequences before convergence at month 66, the other sets of mutations in the light chain, LCDR1-motif#4 and LFWR3-motif#6, converged rapidly without sampling different combinations of mutations. Another representation of the data is presented in Figure 2D , which emphasizes when each SHM sequence motif fully converged to the affinity-mature SHM sequence. Globally, there appears to be three phases, early convergence for HCDR2-motif#3 and LCDR2-motif#5, intermediate convergence for HCDR2-motif#2 and LFWR3-motif#6 and late convergence for HCDR1-motif#1, LCDR1-motif#4, LCDR3-motif#7 (Figures 2D and 2E) . Overall, these results convey a complex affinity maturation process where different sequences are sampled for each SHM motif that then become fixed at different time points, in response to changes in the autologous virus swarm over time.
The PCIN63-UCA Does Not Bind to Env Proteins from Time Points Preceding Initiation of the Lineage
To better define the affinity maturation pathway for the PCIN63 lineage, we next determined the PCIN63 unmutated common ancestor (UCA). For the HC, an unmutated common ancestor (PCIN63-UCA-HC) was identified from the 40 mpi time point. However, for the light chain, lineage assignment based solely on V K +J K gene usage and 5-residue LCDR3 criteria identified 18 unmutated putative precursor light chain sequences from the NGS dataset. The most frequent putative unmutated light chain sequence had an LCDR3 with amino-acid sequence QQSEA and was named PCIN63-UCA-KC1 ( Figure 3A ). The second most frequent unmutated light chain sequence with matching V K +J K genes had an LCDR3 with amino-acid sequence QLYET, similar to the LCDR3 of the least mutated PCIN63-light chain sequences found at 40 mpi and was named PCIN63-UCA-KC2 ( Figure 3A) . To functionally characterize these putative UCAs, all 18 light chain variants were subsequently paired with the PCIN63-UCA-HC (UCA1-UCA18) and first tested for binding to VRC01-class germline targeting immunogens ( Figure 3B ). Only three Abs, including UCA2 but not UCA1, bound to eOD-GT8 with affinities lower to several recently described putative VRC01-class bnAb precursors (Havenar-Daughton et al., 2018) .
We next determined whether the PCIN63-UCA variants could bind to autologous envelope sequences isolated from the PC063 donor. Autologous envelopes were sequenced by NGS and single genome amplification (SGA) at each time point before 40 mpi ( Figure S4A ). As described for other donors, PC063 Env variants became increasingly resistant to PCIN63 mAbs as mutations accumulated in loop D, CD4bs loop, and V5 loops, resulting in complete escape at month-61 ( Figure S4B ). Notably, among the set of sequences there was one rare virus variant isolated at 28 months post infection (M28cH1), lacking both the N276-and N462-glycans. As described previously, these glycans surround the CD4bs and are thought to obstruct binding of VRC01-class antibodies. However, none of the putative PCIN63-UCA Abs neutralized any of the autologous Env clones tested ( Figure S4C ) and no binding could be detected to the corresponding gp120 proteins captured from lysed pseudovirions or to recombinant gp120 from representative Env clones (Figure S4C) , although, Env variants from 28 and 33 mpi had poor expression and therefore could not be evaluated. Overall, despite the availability of longitudinal sampling, UCA determination for this lineage remains partially ambiguous and the Env variants that triggered the PCIN63 Ab lineage is yet to be confirmed.
Autologous Adaptation to the N276-Glycan Is Associated with Heterologous Neutralization Accommodation of the N276 glycan near the CD4bs is arguably the primary obstacle in eliciting VRC01-class responses. To determine at which point this occurred in the PC63 lineage, we next systematically evaluated the functional contributions of each SHM motif to neutralization breadth and potency. We generated PCIN63-UCA/71I chimeric antibody variants containing or lacking individual SHM motifs and evaluated each variant for neutralization against N276-glycan bearing or lacking autologous viruses as well as against a global heterologous 12-virus panel (deCamp et al., 2014) (Figure 4 ). Pairing the UCA-HC variants with the mature 71I-KC resulted in cross-neutralization of autologous viruses, particularly when HCDR2-motif#2 was introduced to the UCA-HC ( Figure 4A , right). The combined LC SHMs alone allowed weaker neutralization of autologous Env lacking the N276-glycan than N276-bearing clones except when paired with the HCDR2-motif#2. In contrast, the UCA-KC2 variants paired with the mature 71I-HC predominantly neutralized viruses lacking the N276 glycan. These observations not only confirm the critical role of LC mutations in accommodating the N276-glycan but also suggest direct dependence on this glycan for binding of early PCIN63 intermediates to autologous Envs. Overall, pairing the UCA/71I-HC variants with the UCA-KC2 yielded broader autologous neutralization than pairing with UCA-KC1 (Figures 4, S5) . This observation not only support UCA2 as the natural precursor of the PCIN63 lineage but also confirms an important role for the LCDR3 in elicitation of VRC01-class lineages.
Pairing the UCA-KC2 variants with an intermediate HC containing only HCDR2-motif#2 and HFWR3-motif#3 highlighted the co-dependence of LCDR1-motif4 and LFWR3-motif#6 for neutralization of autologous viruses with PNGS at position N276, with a critical role for D32 LC in LCDR1-motif4 ( Figure S4B , middle). The detection of autologous M28cH1 neutralization by almost all Ab variants containing at least one SHM motif suggests it may indeed have been the eliciting variant.
The absence of individual SHM motifs in either the HC or the KC had minimal effects on autologous neutralization when the variants were paired with affinity-mature KC or HC, respectively, indicating redundancy across the SHM motifs for epitope recognition. Although heterologous neutralization was overall correlated with autologous neutralization of N276-glycan bearing viruses, the absence of individual SHM motifs had greater impact on heterologous neutralization, which was most significantly reduced in absence of LCDR1-motif#4. In summary, SHM in HCDR2-motif#2, LCDR1-motif#4 and LFWR3-motif#6 are sufficient for autologous neutralization of variant bearing the N276-glycan by PCIN63 Abs.
PCIN63 bnAbs Engage the N276-Glycan of Some Env Strains
To better understand how the PCIN63 antibody lineage might interact with the N276 and other surrounding glycans, we next tested neutralization against heterologous viruses and their corresponding N276A mutants. The data revealed a hierarchy in the importance of glycans for neutralization by PCIN63 Abs, with N276 R N197 > N262 zN301 > N462/N463 > N448 ( Figure S6 ). This trend is generally consistent with the effects observed for other VRC01-class bnAbs, particularly 12A21 and other Abs bearing a glycine-rich LCDR1 loop (VRC23, VRC27, VRC-CH31) with the exception of VRC-N6 ( Figure S6 , Table S5 ). We also observed significant variation between viral strains in their sensitivity to PCIN63 neutralization, as well as between PCIN63 mAbs in their ability to neutralize a given viral strain (Figure 5A ). These variations were still apparent, although to a lesser extent, when pseudoviruses were produced in GnT I À/À cells (293-S) yielding predominantly Man5 glycans on HIV Env (Figure 5A ) (Doores and Burton, 2010) . The negative effect of glycan removal on neutralization for some viral strains by PCIN63 Abs was greater for N276 than other glycans and suggests that the Abs may directly depend on the N276-glycan for binding or neutralization in the context of some Env strains such as JR-CSF ( Figure 5A ). We evaluated other components of the epitope including surrounding glycans as well as key contact residues on Env and observed a general trend toward dependence on the N276-glycan when other obstructive features are present (JR-CSF) but accommodation of the N276 glycan when surrounding obstructive features are missing (JR-FL), such as the N461-glycan and the lack of N197-and N234-glycans ( Figure 5A ). We next determined whether there were shared motifs that lead to dependence or accommodation of the N276 glycan. An alignment of the PCIN63 antibody sequences that are or are not dependent on the N276-glycan revealed that the subset of PCIN63 antibodies that accommodate the N276 glycan share similar sequence features as the 12A21 antibody ( Figure 5B ). The N276-glycan dependent PCIN63 Abs carried SHM motifs possibly sub-optimal for high-affinity contacts with the CD4bs loop (non-aromatic residue N54 HC ) and V5 loop (Y61 HC ), while N276-glycan accommodating PCIN63 mAbs displayed a fourth Gly residues in LCDR1-motif#4 (G34 LC ) and a more canonical LCDR3-motif#7 with aromatic residues at position 91 and 97 optimal for loop D and V5 loop binding ( Figure 5B ). Additionally, all PCIN63 mAbs also carried R/W19 HC and E/D76 HC mutations possibly involved in N197-glycan interactions. Further corroborating the difference in antibody subsets, we also observed that PCIN63 Abs with N276-glycan dependent or accommodating phenotypes clustered in separate branches of the lineage phylogenetic trees suggesting divergent evolution in response to the N276-glycan for this lineage ( Figure S3D ). Overall, these observations suggest a greater dependence on direct contact with the N276-glycan when the CD4bs loop is less accessible and Env protein contacts sub-optimal.
DISCUSSION
The exceptional breadth of VRC01-class bnAbs and their commonly shared features have long made them favored targets for rational vaccine design (Wu et al., 2010; Zhou et al., 2015) . Despite major progress in the isolation and characterization of VRC01-class antibodies and the design of immunogens to prime VRC01-class precursors by immunization, the field has yet to elicit VRC01-class antibodies by immunization McGuire et al., 2013; Dosenovic et al., 2015; Jardine et al., 2015; Briney et al., 2016b; McGuire et al., 2016; Sok et al., 2016; Tian et al., 2016) . Among other challenges, antibodies of this class can be up to 40% mutated from germline suggesting that during infection, VRC01-class antibodies require putative PCIN63-UCA-KCs, the number of sequences (# seq) found in the NGS dataset and the corresponding LCDR3 amino-acid sequences (right) are also indicated. Residues previously described as important for binding to the HIV Env CD4bs are colored in red.
(B) Binding affinity of PCIN63 mature and putative UCA Abs and VRC01-class inferred germline (VRC01, VRC03, VRC07, 12A12, 12A21, 3BNC60, 3BNC117, VRC-PG04, VRC-CH31) and mature Abs (minVRC01, VRC01, VRC03, VRC07, VRC23, VRC27, 12A12, min12A21, 12A21, 3BNC117, VRC-PG19, VRC-CH31, VRC-N6) for the indicated previously described VH1-2 germline targeting immunogens, as measured by SPR. Data are representative of at least two experiments.
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long periods of affinity maturation to target the occluded epitope that is surrounded by glycans on the HIV Env trimer Sajadi et al., 2018) . The glycan at N276 in particular has been previously described to be a key impediment for VRC01-class antibodies to target the CD4bs (Kong et al., 2016) , and its removal has been shown to enhance the binding and neutralization activity of antibodies of this class. NGS analysis of VRC01 lineage ontogeny using longitudinal samples collected 5-20 years after infection indeed revealed a complex multi-branched lineage . However, late sampling only captured lineage sequences that were heavily mutated preventing the reconstruction of the early stages of VRC01 elicitation and maturation. Here, we describe the first complete longitudinal analysis of VRC01-class antibodies affinity maturation from elicitation to acquisition of neutralization breadth in natural infection. The findings also challenge the current strategies relying on glycan-deleted immunogens to select for Ab with glycan avoiding features and suggest that transient direct glycan-binding may help driving affinity maturation toward broad glycan accommodation. Despite the number of VRC01-class mAbs isolated to date, the field has relied on reverted-germline Abs as templates for vaccine design, which were inferred either by phylogeny of B cell transcripts at a single time point or by reverting the V and J genes and approximating the HCDR3 of mature bnAbs McGuire et al., 2013; Jardine et al., 2015; Dosenovic et al., 2015; Briney et al., 2016b; McGuire et al., 2016; Bonsignori et al., 2018) . Indeed, the uncertainty in determining the PCIN63 lineage precursor light chain despite the availability of contemporaneous samples reveal the importance of small LCDR3 variations on antibody binding, which highlights how sequence approximations could lead to different interpretations of germline antibody binding. We note in the case of PCIN63, both binding to eOD-GT8 and the weak neutralizing activity detected against the M28cH1 glycan-lacking variants by UCA2 chimeric Abs compared to UCA1 suggest but do not formerly validate UCA2 as the true PCIN63 precursor.
Previous studies reported that VRC01-class bnAbs require more time (>5 years) to develop during infection than bnAbs targeting other Env epitopes (1-3 years) Lynch et al., 2012) , a hypothesis supported by the high frequency of SHMs typically found among VRC01-class antibodies (Figure 1) . While there was indeed a late onset for the PCIN63 antibody lineage, neutralization breadth for this lineage was acquired in less than 2 years and isolated mAbs from these time points showed only 10%-15% mutation from germline, which is 2-to 3-fold lower than typical VRC01-class antibodies. PCIN63 is the second VK1-5+ VRC01-subclass bnAb lineage isolated to date (Sajadi et al., 2018) . Together with the recent finding that the VK1-5+ subclass of potential VRC01-class precursors were nearly as common as the most frequent VK3-20+ eOD-GT8-specific B cells in naive donor repertoires (Havenar-Daughton et al., 2018) , this suggest (1) that the naive B cells isolated using germline-targeting immunogens may indeed represent true bnAbs precursors and (2) that this particular subclass of bnAbs may serve as a favorable target for vaccine design. Furthermore, evaluation of factors that might have favored the elicitation and focused affinity maturation of the PCIN63 lineage in donor PC063, i.e., frequencies of VRC01-class precursors and biased AID hotspots (see Methods) favoring affinity maturation at key contact residues, showed no significant differences compared to other donors. This suggests that similar focused maturation of PCIN63-like antibodies, with more classical features compared to other bnAbs of this class, might be readily achievable by vaccination.
To inform VRC01-class antibodies targeting vaccine strategies, we thus phylogenetically retraced the evolution of key SHM motifs and functionally tested their contribution to autologous and heterologous neutralization. The observation that PCIN63 lineage heavy chain sampled a greater sequence diversity compared to the light chain is consistent with a stringent selection pressure on the light chain to accommodate glycans surrounding the CD4bs followed by honing of the antibodyepitope interactions through gradual selection of affinity mutations in the heavy chain. Previous studies demonstrated that VRC01-class bnAbs SHM in the LC specifically were critical for the adaptation to the N276-and V5-loop glycans and are required for neutralization breadth. Accordingly, most immunization strategies are designed to prime VRC01-class precursors with immunogens lacking these glycans (eOD-GT8, 426c and donor NIH-45 Env derived molecules). In these studies, the Abs elicited by glycan-lacking priming immunogens typically cannot bind or neutralize Env constructs with the N276-glycan present. The responses are then typically boosted with more native-like Env proteins incrementally incorporating glycans to select for HC and LC mutations that enable binding in the presence of the N276 glycan. However, this strategy has only shown success in models where precursor frequencies are high or when the animal model contains an affinity-mature VRC01-class heavy-or light-chain gene Dosenovic et al., 2015; Jardine et al., 2015; McGuire et al., 2016; Sok et al., 2016; Tian et al., 2016) .
Here we showed that UCA-HC/mature-KC chimeric Ab displayed weak neutralizing activity of the N276-glycan bearing autologous clones but not of their N276-glycan KO counterpart suggesting that direct engagement of the N276-glycan may Table S5. have facilitated binding. The lineage then affinity matures into two main branches, where one remains dependent on the N276 glycan for binding and the other gaining affinity for the CD4bs epitope in the absence of the N276 glycan. Together with the recent finding that VRC01 inferred GL Ab interacted with the N276-glycan of 426c gp120 core lacking the V1-V2-V3 loops (Borst et al., 2018) , these data suggest an alternative vaccine design strategy where the N276-glycan is present on the germline-targeting immunogens at the initial priming stages to select for early intermediates with glycan-binding properties, which could be subsequently boosted with immunogens to affinity mature intermediate precursors to relinquish dependency on the glycan and acquire higher affinity for the CD4bs epitope. A similar strategy was suggested for V2-apex directed Abs upon observation that varying affinities for particular glycoforms were associated with the elicitation of the PCT64 lineage (Landais et al., 2017 , Rantalainen et al., 2018 .
To better understand the putative interactions between PCIN63 Abs and the Env trimer, we constructed an in silico model of 12A21 bound to BG505 SOSIP.664 using independently published structures (Klein et al., 2013; Zhang et al., 2018) (Figure 6 ). This model suggests contacts between E62 and CDR2-N57 HC , and N279 and CDR3-E96 LC consistent with the strain-specific N276-glycan dependent variations observed in Figure 5A . Together with the evidence of early N276-glycan binding and significant toggling of the HCDR2-motif#2, this model suggests that PCIN63 Abs maturation pathway required a fine balance between glycan avoidance to better access the CD4bs loop and Loop D contact residues, and direct glycan binding to counter lower affinity of early viral intermediates evolving to escape autologous Ab responses. While acquiring a deletion in LCDR1 to avoid the N276-glycan, as seen in most VRC01-class Abs, might be more difficult to reproduce by vaccination, our data suggest that immunization strategies should not focus on glycan-deleted immunogens alone to drive affinity maturation of this lineage.
The trajectory for affinity maturation to broadly neutralizing antibodies in natural infection follows complex pathways with many ''dead-ends'' (Bhiman et al., 2015; Sok et al., 2014) that may be avoided with more focused and targeted rational vaccine design strategies. The isolation of the PCIN63 bnAbs and the identification of their UCA will enable the development of a germline mouse model for a CD4bs lineage known to develop broadly neutralizing activity. Finally, the identification of antibody intermediates and viral sequences will enable the evaluation of candidate boosts to refine immunization schemes that might drive such responses by vaccination.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: In silico modeling of 12A21 bound to BG505 SOSIP.664 using the published structures of 12A21 bound to gp120 (PDB ID: 4JPW) (Klein et al., 2013) and glycosylated BG505 SOSIP.664 bound to 35O22 and PGT122 (PDB ID: 6DE7) . Two of the three Env protomers are displayed in shades of gray as transparent surfaces highlighting the CD4bs loop (red), loop D (orange), the V5 loop (yellow) on one protomer and other putative contact residues (cyan) on the second protomer. Glycans surrounding the CD4bs protruding from both protomers are shown as brown spheres and labeled. 12A21 HC and LC residues corresponding to PCIN63 SHM motifs are shown as ribbon and color-coded as defined in Figure 2B 
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Some authors have filed a patent application whose subject matter relates to this work. . Donor PC063 is a female participant enrolled in the Protocol C longitudinal primary infection cohort at 34-year of age, approximately 7 weeks (2 months) after heterosexual infection by a subtype C HIV-1 virus and was identified as one of the top 20% neutralizers, neutralizing up to 85% of viruses on a 37-virus panel . The neutralizing activity was first detected in the plasma after 5 year of infection and steadily increased to reach a peak at 6 years, neutralizing 79% of viruses from a large panel Landais et al., 2016) . The plasma broadly neutralizing activity was mapped to the CD4 binding site as it was competed by RSC3 and its absorption with rgp120 monomers was competed by b6 and sensitive to the D168R mutation .
Cell Lines
The female HEK-derived 293T, HEK293S N-acetylglucosaminyltransferase I-negative (GnTIÀ/À), and HeLa-derived TZM-bl cell lines were maintained in complete Dulbecco's Modified Eagle Medium (herein referred to as cDMEM) containing high-glucose Dulbecco's Modified Eagle Medium (DMEM, Thermo Fisher), 1X Penicillin-Streptomycin (Pen Strep, Thermo Fisher) and 10% fetal bovine serum (FBS, Gemini Bio Products) at 37 C and 5% CO 2 . FreeStyle HEK-derived 293F cells (Thermo Fisher) were maintained in Freestyle 293 Expression Medium at 37 C and 10% CO 2 with shaking at 120 RPM.
METHODS DETAILS
Single memory B cell sorting and isolation of PCIN63 monoclonal antibodies Sorting of antigen-and epitope-specific memory B cells was performed as previously described (MacLeod et al., 2016; Sok et al., 2014; Tiller et al., 2008; Wu et al., 2010) . Fluorescent-labeled antibodies recognizing cell surface markers were purchased from BD Biosciences. AVI-tagged WT and D368R YU2-gp140-Foldon proteins (plasmid generously provided by Y. Li) were produced, purified, labeled with biotin (Avidity), and coupled to streptavidin-PE, streptavidin-APC (Life Technologies), and streptavidin-BV421 (BD Biosciences), as previously described . Cells were stained with the Live/Dead Fixable Near-IR Dead Cell Stain Kit (Life Technologies) for 30 min on ice according to the manufacturer's instructions. Cells were then labeled with antibodies for surface markers together with probes for 1 hour in Brilliant Stain buffer (BD Biosciences) on ice. Cells were sorted into individual wells of a 96 well plate containing First Strand buffer containing DTT and RNaseOUT (Life Technologies) using a BD FACSAria III sorter and were immediately sealed and stored at-80 C after sorting each plate. cDNA was generated from cells sorted into lysis buffer using Superscript III Reverse Transcriptase (Life Technologies) and random hexamers (Gene Link). Nested PCR amplification of heavy-and light-chain variable regions was performed using Multiplex PCR Kit (QIAGEN) and previously described primer sets (Tiller et al., 2008) . Amplified heavy-and light-chain variable regions were sequenced and subsequently analyzed using IMGT (the International ImMunoGeneTics Information System, www.imgt.org) V-quest (Lefranc et al., 2009) .
Antibodies of interest were cloned into expression vectors (Tiller et al., 2008) by re-amplification of sequences using the same primers but modified to introduce homology to the cut ends of the vector, and cloning was performed using the Seamless Cloning and Assembly Enzyme mix (Life Technologies) in expression vectors with the appropriate IgG1, Ig kappa or Ig lambda constant domain. Antibodies incorporating targeted amino acid mutations were generated by Quickchange mutagenesis (Stratagene).
PCIN63 antibody expression and purification
Antibodies HC and LC constructs were transiently expressed with the FreeStyle 293 Expression System (Invitrogen). Supernatant was collected after 4-5 days of culture and whole IgGs were purified with Protein A Sepharose (GE Healthcare). Purified proteins purity and integrity checked by SDS-PAGE.
B cell repertoire next generation sequencing and computational analysis RNA was prepared (RNEasy kit, QIAGEN) from total PBMCs (a single of 10 million cells per time point) and was subjected to reverse transcription using barcoding primers that contain unique Ab identifiers as previously described . The cDNA was
